Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Appendix 3.0: Formulary UK Oral Mucositis in Cancer Group | Mouth care guidance and support in cancer and palliative care Product Product Category Analgesia Indication Benzydamine Oromucosal spray and mouthwash Difflam® that acts as local analgesics and antiinflammatory treatment for the relief of painful inflammatory conditions of the mouth and throat Contains ethanol Xylocaine 10% Spray Unlicensed use Apply thinly using cotton bud on ulcer Caphosol® Not intended to be swallowed Should not spray at rear of oral cavity due to risk of possible aspiration Lidocaine 5% Water miscible - apply sparingly on affected area Mouth Rinse Special Considerations Should not apply at rear of oral cavity due to risk of possible aspiration An oral rinse used for patients with dryness of the mouth and oropharynx It is indicated as an adjunct to standard oral care in both the prevention and treatment of mucositis Mucosal Protectant Systemic Therapies OraLife Mouthwash Designed to aid cleaning and hygiene Episil® An oral liquid that may be used to relieve pain in patients suffering from oral mucositis Do not use this product if the patient is allergic to peanut or soya GelClair® A gel that helps in the management of lesions of the oropharyngeal cavity, by forming a protective film that helps to provide pain relief, soothing mouth lesions Can be applied directly to mucosa without dilution MuGard® A mucoadhesive oral wound rinse indicated for the management of oral mucositis/stomatitis Licensing and supply issues. (Available in USA but not in many European countries) Folinic Acid Used to counteract the folate antagonist action of methotrexate (given as calcium folinate) Palifermin Relieves sensation of dry mouth An intravenous injection containing human keratinocyte growth factor, indicated for the management of oral mucositis Products currently being re-formulated Appendix 3.1: Formulary UK Oral Mucositis in Cancer Group | Mouth care guidance and support in cancer and palliative care Product Product Category Indication Special Considerations Systemic Therapies Salagen® Pilocarpine An oral tablet used for the treatment of xerostomia following irradiation for head and neck cancer Should only be used in patients who have some residual salivary gland function Artificial Saliva AS Saliva Orthana® Oral spray and lozenges used for patients suffering from dry mouth Not suitable for vegetarians, halal or kosher diets Biotène® products Various products which provide symptomatic treatment of dry mouth Contains lactulose BioXtra® products Oral spray and gel used for patients suffering from dry mouth Glandosane® An aerosol spray used for patients suffering from dry mouth Not suitable for vegetarian halal or kosher diet Due to high PH has the potential to damage the teeth enamel Salivary Stimulants Other SalivezeTM An oral spray used for patients suffering from dry mouth Xerotin® A spray used for symptomatic treatment of dry mouth Sugar free Salivix® Oral pastilles used for patients suffering from dry mouth Sugar free Salivary Stimulating Tablets SST® Tablets used for the symptomatic treatment of dry mouth in patients with impaired salivary gland function OraLife Gel Contains adelmidrol to stablise mast cells and prevent/relieve symptoms of OM TraLife Spray Anti-inflammatory barrier spray for OM and throat problems Chlorhexidine May help in cleaning the oral cavity when normal brushing is not possible after oral surgery May be contra-indicated when someone has evidence of OM. Generally contra-indicated in the head and neck setting